Bausch + Lomb

Company Overview

Bausch + Lomb is a key developer and manufacturer of eye care products. The company was founded in 1853 and is headquartered in Canada. In August 2013, Bausch + Lomb was acquired by Bausch Health Companies Inc. (formerly known as Valeant Pharmaceuticals International Inc.) and became the eye care division of Bausch Health.

Bausch + Lomb is a fully integrated eye health business with a 170-year legacy. The company has an established line of contact lenses, IOLs and other medical devices, surgical systems and devices, vitamin and mineral supplements, lens care products, prescription eye medications, and other consumer products.

Financial Highlights (FY 2023)

Company's Business Segments

• Vision Care : The Vision Care segment consists of Consumer Eye Care Contact Lens businesses. Consumer Eye Care business consists of Contact Lens care products OTC Eye Drops that address various conditions, including Eye Allergies, Conjunctivitis, Dry eye, Redness Relief, Eye Vitamin, and Mineral Supplements. Contact Lens business includes sales of Traditional Replacement Disposable, Planned Replacement Disposable, and Daily Disposable Soft Contact Lenses.
• Pharmaceuticals : The pharmaceuticals segment consists of a broad line of Proprietary Pharmaceutical Products, Generic Pharmaceutical Products for Post-operative Treatments, and Treatments for a number of Eye Conditions, such as Glaucoma, Eye Inflammation, Ccular Hypertension, Dry Eyes, and Retinal Diseases.
• Surgical : The surgical segment consists of Medical Device Equipment, Consumables, and Technologies for the treatment of Cataracts, Corneal, Vitreous, and Retinal Eye Conditions, which includes IOLs, Delivery Systems, Phacoemulsification Equipment, Other Surgical Instruments necessary for Cataract Surgery.